Market Closed -
Canadian Securities Exchange
12:50:35 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
0.02
CAD
|
0.00%
|
|
-20.00%
|
-20.00%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9.717
|
5.594
|
14.6
|
3.656
|
3.878
|
Enterprise Value (EV)
1 |
9.204
|
5.724
|
7.003
|
2.723
|
3.99
|
P/E ratio
|
-9.19
x
|
-1.53
x
|
-1.23
x
|
-0.29
x
|
-0.55
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
12.6
x
|
6.32
x
|
-
|
-
|
4.61
x
|
EV / Revenue
|
11.9
x
|
6.47
x
|
-
|
-
|
4.75
x
|
EV / EBITDA
|
-3.64
x
|
-1.84
x
|
-1.14
x
|
-0.66
x
|
-1.2
x
|
EV / FCF
|
-119,268,553
x
|
-22,910,278
x
|
-1,761,136
x
|
5,246,847
x
|
-4,203,548
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
0%
|
-0%
|
Price to Book
|
1.59
x
|
0.83
x
|
1.29
x
|
8.2
x
|
-12.4
x
|
Nbr of stocks (in thousands)
|
11,169
|
13,319
|
37,439
|
38,488
|
155,136
|
Reference price
2 |
0.8700
|
0.4200
|
0.3900
|
0.0950
|
0.0250
|
Announcement Date
|
12/24/19
|
12/21/20
|
12/24/21
|
12/22/22
|
2/15/24
|
Fiscal Period: August |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.5674
|
0.7738
|
0.8848
|
-
|
-
|
0.8405
|
EBITDA
1 |
-3.047
|
-2.531
|
-3.107
|
-6.162
|
-4.113
|
-3.316
|
EBIT
1 |
-3.293
|
-2.903
|
-3.323
|
-6.378
|
-4.123
|
-3.359
|
Operating Margin
|
-580.28%
|
-375.1%
|
-375.56%
|
-
|
-
|
-399.67%
|
Earnings before Tax (EBT)
1 |
-11.1
|
-0.7544
|
-3.436
|
-23.84
|
-12.25
|
-4.502
|
Net income
1 |
-11.1
|
-0.7544
|
-3.436
|
-9.658
|
-12.25
|
-4.707
|
Net margin
|
-1,956.29%
|
-97.5%
|
-388.33%
|
-
|
-
|
-560.04%
|
EPS
2 |
-2.602
|
-0.0947
|
-0.2738
|
-0.3170
|
-0.3236
|
-0.0451
|
Free Cash Flow
|
-
|
-0.0772
|
-0.2498
|
-3.976
|
0.519
|
-0.9493
|
FCF margin
|
-
|
-9.97%
|
-28.24%
|
-
|
-
|
-112.94%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/30/19
|
12/24/19
|
12/21/20
|
12/24/21
|
12/22/22
|
2/15/24
|
Fiscal Period: August |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
0.13
|
-
|
-
|
0.11
|
Net Cash position
1 |
2.49
|
0.51
|
-
|
7.6
|
0.93
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-0.0418
x
|
-
|
-
|
-0.0338
x
|
Free Cash Flow
|
-
|
-0.08
|
-0.25
|
-3.98
|
0.52
|
-0.95
|
ROE (net income / shareholders' equity)
|
-
|
-15.5%
|
-37.6%
|
-195%
|
-209%
|
-3,297%
|
ROA (Net income/ Total Assets)
|
-
|
-26.3%
|
-21.1%
|
-31.8%
|
-37.2%
|
-104%
|
Assets
1 |
-
|
2.867
|
16.29
|
30.37
|
32.92
|
4.537
|
Book Value Per Share
2 |
0.0600
|
0.5500
|
0.5100
|
0.3000
|
0.0100
|
-0
|
Cash Flow per Share
2 |
0.0400
|
0.0500
|
0.0100
|
0.0300
|
0.0200
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/30/19
|
12/24/19
|
12/21/20
|
12/24/21
|
12/22/22
|
2/15/24
|
|
1st Jan change
|
Capi.
|
---|
| -20.00% | 2.41M | | +40.09% | 6.16B | | -16.34% | 4.46B | | -7.11% | 3.27B | | +5.14% | 3.2B | | -0.18% | 2.6B | | +47.93% | 1.98B | | -7.15% | 1.7B | | +0.67% | 1.66B | | -8.73% | 1.61B |
Alternative Medicine
|